"Oseltamivir"[nm] - Search Results

Year	Number of Results
1997	3
1998	12
1999	19
2000	32
2001	31
2002	46
2003	49
2004	50
2005	85
2006	107
2007	120
2008	133
2009	280
2010	394
2011	360
2012	277
2013	234
2014	200
2015	193
2016	153
2017	150
2018	137
2019	137
2020	175
2021	118
2022	106
2023	71
2024	49

1

Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023-February 2024.

Patel MC, Nguyen HT, Pascua PNQ, Gao R, Steel J, Kondor RJ, Gubareva LV. Patel MC, et al. Emerg Infect Dis. 2024 Jul;30(7):1410-1415. doi: 10.3201/eid3007.240480. Emerg Infect Dis. 2024. PMID: 38916572 Free PMC article.

2

Oseltamivir Does Not Reduce the Likelihood of Hospitalization in Adults.

Ebell MH. Ebell MH. Am Fam Physician. 2024 Jun;109(6):580. Am Fam Physician. 2024. PMID: 38905562 No abstract available.

3

A noninferiority randomized open-label pilot study of 3- versus 7-day influenza postexposure prophylaxis with oseltamivir in hospitalized children.

Wrotek A, Jackowska T. Wrotek A, et al. Sci Rep. 2024 Jun 20;14(1):14192. doi: 10.1038/s41598-024-65244-5. Sci Rep. 2024. PMID: 38902383 Free PMC article. Clinical Trial.

4

A case of amenorrhea: Caused by Oseltamivir or Influenza a virus?

Zhou P, Li S. Zhou P, et al. Am J Reprod Immunol. 2024 May;91(5):e13867. doi: 10.1111/aji.13867. Am J Reprod Immunol. 2024. PMID: 38796739 No abstract available.

5

Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.

Franco-May DA, Gómez-Carballo J, Barrera-Badillo G, Cruz-Ortíz MN, Núñez-García TE, Arellano-Suárez DS, Wong-Arámbula C, López-Martínez I, Wong-Chew RM, Ayora-Talavera G. Franco-May DA, et al. Antiviral Res. 2024 Jul;227:105918. doi: 10.1016/j.antiviral.2024.105918. Epub 2024 May 23. Antiviral Res. 2024. PMID: 38795911 Free article.

6

In Vivo Immune-Modulatory Activity of Lefamulin in an Influenza Virus A (H1N1) Infection Model in Mice.

Paukner S, Kimber S, Cumper C, Rea-Davies T, Sueiro Ballesteros L, Kirkham C, Hargreaves A, Gelone SP, Richards C, Wicha WW. Paukner S, et al. Int J Mol Sci. 2024 May 15;25(10):5401. doi: 10.3390/ijms25105401. Int J Mol Sci. 2024. PMID: 38791439 Free PMC article.

7

Pharmacoeconomic study of anti-influenza virus drugs in Japan based on a network meta-analysis.

Nakagawa N, Kanazawa Y, Morikawa A, Lai L. Nakagawa N, et al. J Antimicrob Chemother. 2024 Jul 1;79(7):1590-1596. doi: 10.1093/jac/dkae141. J Antimicrob Chemother. 2024. PMID: 38775746

8

Modular Biomimetic Strategy Enables Discovery and SAR Exploration of Oxime Macrocycles as Influenza A Virus (H1N1) Inhibitors.

Xu D, Gong Y, Zhang L, Xiao F, Wang X, Qin J, Tan L, Yang T, Lin Z, Xu Z, Liu X, Xiao F, Zhang F, Tang F, Zuo J, Luo X, Huang W, Yang L, Yang W. Xu D, et al. J Med Chem. 2024 May 23;67(10):8201-8224. doi: 10.1021/acs.jmedchem.4c00319. Epub 2024 May 13. J Med Chem. 2024. PMID: 38736187

9

Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.

Li Y, Wang X, Liao Y, Zeng Y, Lin W, Zhuang W. Li Y, et al. BMC Infect Dis. 2024 May 9;24(1):446. doi: 10.1186/s12879-024-09339-4. BMC Infect Dis. 2024. PMID: 38724914 Free PMC article.

10

Assessing the impact of antiviral drugs commonly utilized during the COVID-19 pandemic on the embryonic development of Xenopus laevis.

Laçin C, Turhan DO, Güngördü A. Laçin C, et al. J Hazard Mater. 2024 Jul 5;472:134462. doi: 10.1016/j.jhazmat.2024.134462. Epub 2024 Apr 27. J Hazard Mater. 2024. PMID: 38718506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

3,343 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

3,343 results

Results by year